250
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review

, , , , &
Pages 165-187 | Published online: 11 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Thommas M. Musyoka, Aquillah M. Kanzi, Kevin A. Lobb & Özlem Tastan Bishop. (2016) Analysis of non-peptidic compounds as potential malarial inhibitors against Plasmodial cysteine proteases via integrated virtual screening workflow. Journal of Biomolecular Structure and Dynamics 34:10, pages 2084-2101.
Read now

Articles from other publishers (15)

Erick Tavares Marcelino Alves, Filipe Gomes Pernichelle, Lucas Adriano Nascimento, Glaucio Monteiro Ferreira & Elizabeth Igne Ferreira. (2023) Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options. Pharmaceuticals 16:7, pages 1028.
Crossref
Lik Tong Tan & Ma Yadanar Phyo. (2020) Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets. Molecules 25:9, pages 2197.
Crossref
Thommas Mutemi Musyoka, Joyce Njoki Njuguna & Özlem Tastan Bishop. (2019) Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design. Malaria Journal 18:1.
Crossref
Rafael Pinto Vieira, Viviane Corrêa Santos & Rafaela Salgado Ferreira. (2019) Structure-based Approaches Targeting Parasite Cysteine Proteases. Current Medicinal Chemistry 26:23, pages 4435-4453.
Crossref
Mohd Asad, Azhar Muneer, Pradeep Kumar, Vandana Thakur, Sumit Rathore, Pawan Malhotra & Asif Mohmmed. 2019. Pathogenicity and Drug Resistance of Human Pathogens. Pathogenicity and Drug Resistance of Human Pathogens 181 211 .
Ayodeji A. Agbowuro, Wilhelmina M. Huston, Allan B. Gamble & Joel D. A. Tyndall. (2018) Proteases and protease inhibitors in infectious diseases. Medicinal Research Reviews 38:4, pages 1295-1331.
Crossref
Lik Tong Tan. 2017. Natural Products Targeting Clinically Relevant Enzymes. Natural Products Targeting Clinically Relevant Enzymes 19 43 .
Emir Salas-Sarduy, Yasel Guerra, Giovanni Covaleda Cortés, Francesc Avilés & María Chávez Planes. (2017) Identification of Tight-Binding Plasmepsin II and Falcipain 2 Inhibitors in Aqueous Extracts of Marine Invertebrates by the Combination of Enzymatic and Interaction-Based Assays. Marine Drugs 15:4, pages 123.
Crossref
Vasanthanathan Poongavanam & Jacob Kongsted. (2016) Binding affinity models for Falcipain inhibition based on the Linear Interaction Energy method. Journal of Molecular Graphics and Modelling 70, pages 236-245.
Crossref
Rudi Oliveira, Daniela Miranda, Joana Magalhães, Rita Capela, Maria J. Perry, Paul M. O’Neill, Rui Moreira & Francisca Lopes. (2015) From hybrid compounds to targeted drug delivery in antimalarial therapy. Bioorganic & Medicinal Chemistry 23:16, pages 5120-5130.
Crossref
Sai Kumar Chakka, Mohammad Kalamuddin, Srividhya Sundararaman, Lianhu Wei, Sourabh Mundra, Radhakrishnan Mahesh, Pawan Malhotra, Asif Mohmmed & Lakshmi P. Kotra. (2015) Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents. Bioorganic & Medicinal Chemistry 23:9, pages 2221-2240.
Crossref
Elke Persch, Oliver Dumele & François Diederich. (2015) Molecular Recognition in Chemical and Biological Systems. Angewandte Chemie International Edition 54:11, pages 3290-3327.
Crossref
Elke Persch, Oliver Dumele & François Diederich. (2015) Molekulare Erkennung in chemischen und biologischen Systemen. Angewandte Chemie 127:11, pages 3341-3382.
Crossref
Jinghui Wang, Feng Li, Yan Li, Yinfeng Yang, Shuwei Zhang & Ling Yang. (2013) Structural features of falcipain-3 inhibitors: an in silico study. Molecular BioSystems 9:9, pages 2296.
Crossref
Sumit Rathore, Shaifali Jain, MohD Asad, Gaurav Datta, Pawan Malhotra & Asif Mohmmed. 2013. Proteases in Health and Disease. Proteases in Health and Disease 215 242 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.